Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 4
2021 19
2022 15
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection.
Havervall S, Marking U, Svensson J, Greilert-Norin N, Bacchus P, Nilsson P, Hober S, Gordon M, Blom K, Klingström J, Åberg M, Smed-Sörensen A, Thålin C. Havervall S, et al. N Engl J Med. 2022 Oct 6;387(14):1333-1336. doi: 10.1056/NEJMc2209651. Epub 2022 Sep 14. N Engl J Med. 2022. PMID: 36103621 Free PMC article. No abstract available.
Mucosal immune responses following a fourth SARS-CoV-2 vaccine dose.
Bladh O, Marking U, Havervall S, Norin NG, Aguilera K, Hober S, Smed-Sörensen A, Gordon M, Blom K, Åberg M, Klingström J, Thålin C. Bladh O, et al. Among authors: havervall s. Lancet Microbe. 2023 Jul;4(7):e488. doi: 10.1016/S2666-5247(23)00102-7. Epub 2023 Apr 20. Lancet Microbe. 2023. PMID: 37086736 Free PMC article. No abstract available.
Mucosal and Serum Antibodies 3 Weeks after Symptomatic BA.2.86 Infection.
Bladh O, Greilert-Norin N, Havervall S, Marking U, Aguilera K, Alm JJ, Blom K, Åberg M, Klingström J, Thålin C. Bladh O, et al. Among authors: havervall s. N Engl J Med. 2023 Oct 26;389(17):1626-1628. doi: 10.1056/NEJMc2310347. N Engl J Med. 2023. PMID: 37888924 Free PMC article. No abstract available.
Correlates of protection and viral load trajectories in omicron breakthrough infections in triple vaccinated healthcare workers.
Marking U, Havervall S, Norin NG, Bladh O, Christ W, Gordon M, Ng H, Blom K, Phillipson M, Mangsbo S, Alm JJ, Smed-Sörensen A, Nilsson P, Hober S, Åberg M, Klingström J, Thålin C. Marking U, et al. Among authors: havervall s. Nat Commun. 2023 Mar 22;14(1):1577. doi: 10.1038/s41467-023-36984-1. Nat Commun. 2023. PMID: 36949041 Free PMC article.
Tissue factor activity of small and large extracellular vesicles in different diseases.
Sachetto ATA, Archibald SJ, Hisada Y, Rosell A, Havervall S, van Es N, Nieuwland R, Campbell RA, Middleton EA, Rondina MT, Thålin C, Mackman N. Sachetto ATA, et al. Among authors: havervall s. Res Pract Thromb Haemost. 2023 Mar;7(3):100124. doi: 10.1016/j.rpth.2023.100124. Epub 2023 Mar 15. Res Pract Thromb Haemost. 2023. PMID: 37012986 Free PMC article.
Mucosal IgA protects against BQ.1 and BQ.1.1 infection.
Marking U, Bladh O, Havervall S, Greilert-Norin N, Gordon M, Alm JJ, Blom K, Åberg M, Klingström J, Thålin C. Marking U, et al. Among authors: havervall s. Lancet Infect Dis. 2023 Aug;23(8):e272-e273. doi: 10.1016/S1473-3099(23)00421-8. Epub 2023 Jul 12. Lancet Infect Dis. 2023. PMID: 37453441 No abstract available.
Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variants.
Monteil V, Eaton B, Postnikova E, Murphy M, Braunsfeld B, Crozier I, Kricek F, Niederhöfer J, Schwarzböck A, Breid H, Devignot S, Klingström J, Thålin C, Kellner MJ, Christ W, Havervall S, Mereiter S, Knapp S, Sanchez Jimenez A, Bugajska-Schretter A, Dohnal A, Ruf C, Gugenberger R, Hagelkruys A, Montserrat N, Kozieradzki I, Hasan Ali O, Stadlmann J, Holbrook MR, Schmaljohn C, Oostenbrink C, Shoemaker RH, Mirazimi A, Wirnsberger G, Penninger JM. Monteil V, et al. Among authors: havervall s. EMBO Mol Med. 2022 Aug 8;14(8):e15230. doi: 10.15252/emmm.202115230. Epub 2022 Jul 4. EMBO Mol Med. 2022. PMID: 35781796 Free PMC article.
Impact of SARS-CoV-2 infection on vaccine-induced immune responses over time.
Havervall S, Marking U, Greilert-Norin N, Gordon M, Ng H, Christ W, Phillipson M, Nilsson P, Hober S, Blom K, Klingström J, Mangsbo S, Åberg M, Thålin C. Havervall S, et al. Clin Transl Immunology. 2022 Apr 18;11(4):e1388. doi: 10.1002/cti2.1388. eCollection 2022. Clin Transl Immunology. 2022. PMID: 35444806 Free PMC article.
7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection.
Marking U, Bladh O, Havervall S, Svensson J, Greilert-Norin N, Aguilera K, Kihlgren M, Salomonsson AC, Månsson M, Gallini R, Kriegholm C, Bacchus P, Hober S, Gordon M, Blom K, Smed-Sörensen A, Åberg M, Klingström J, Thålin C. Marking U, et al. Among authors: havervall s. Lancet Infect Dis. 2023 Feb;23(2):150-152. doi: 10.1016/S1473-3099(22)00834-9. Epub 2023 Jan 11. Lancet Infect Dis. 2023. PMID: 36640796 Free PMC article. No abstract available.
40 results